Advertisement
Regulatory
Subscribe to Regulatory
View Sample

FREE Email Newsletter

Summary Information for: Resolute MicroTrac Zotarolimus-Eluting Coronary Stent System (Resolute MicroTrac) and Resolute Integrity Zotarolimus-Eluting Coronary Stent System (Re...

March 7, 2012 4:30 am | by U.S. Food & Drug Administration | News | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for Resolute MicroTrac Zotarolimus-Eluting Coronary Stent System (Resolute MicroTrac) and Resolute Integrity Zotarolimus-Eluting Coronary Stent System (Resolute Integrity) (P110013).

Consumer Information on: Breast Companion & #xae; Software System - P100007

March 6, 2012 7:32 am | by U.S. Food & Drug Administration | News | Comments

The Breast Companion® Software System is a computer-aided report-generating system intended to improve the ACR BI-RADS® (American College of Radiology, Breast Imaging Reporting and Data System) assessment of ultrasound images of lesions of the...

Summary Information for: Breast Companion & #xae; Software System

March 6, 2012 7:32 am | by U.S. Food & Drug Administration | News | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for Breast Companion® Software System (P100007).

Advertisement

Houston Medical Robotics, Inc. Receives FDA 510(k) Clearance for Euclid Tier 1 Mini Access System

March 6, 2012 4:48 am | News | Comments

Houston Medical Robotics, Inc. announces that it has received U.S. Food and Drug Administration 510(k) clearance to market the Euclidâ„¢ Tier 1 Mini Access System. The Euclidâ„¢ Tier 1 Mini Access System is a portable, hand-held device that integrates commercially available...

Summary Information for: Ovation Abdominal Stent Graft System

March 5, 2012 5:31 am | by U.S. Food & Drug Administration | News | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for Ovation Abdominal Stent Graft System (H100008).

Consumer Information on: OVATION Abdominal Stent Graft System - H100008

March 5, 2012 5:31 am | by U.S. Food & Drug Administration | News | Comments

The OVATION abdominal stent graft system is used to treat abdominal aortic aneurysms during endovascular repair (EVAR). An aneurysm is a diseased, bulging, weak section of an artery wall; in this case the aorta. The main portion of the OVATION abdominal..

Cardiac Science Powerheart, CardioVive, CardioLife; GE Responder and Responder Pro; and Nihon-Kohden Automated External Defibrillators (AEDs): Class I Recall - Defective Compo...

March 2, 2012 2:31 pm | by U.S. Food & Drug Administration | News | Comments

Unexpected component failure may lead to AEDs not delivering defibrillation therapy, causing serious adverse health consequences, including death.

Class I Medical Device Recall: Cardiac Science Powerheart, CardioVive, CardioLife; GE Responder and Responder Pro; and Nihon-Kohden Automated External Defibrillators - AEDs

March 2, 2012 7:30 am | by U.S. Food & Drug Administration | News | Comments

The affected AEDs contain a component that may fail unexpectedly due to a defect. If the component were to fail during a rescue attempt, the AED may not deliver defibrillation therapy causing serious adverse health consequences

Advertisement

Statins and HIV or Hepatitis C Drugs: Drug Safety Communication - Interaction Increases Risk of Muscle Injury

March 1, 2012 11:30 am | by U.S. Food & Drug Administration | News | Comments

Protease inhibitors and statins taken together may raise the blood levels of statins and increase the risk of myopathy, kidney damage, and kidney failure, which can be fatal.

Safety tips for intense pulsed light therapy

March 1, 2012 4:31 am | by U.S. Food & Drug Administration | News | Comments

Article originally published in Nursing2012, February issue. DEVICE SAFETY INTENSE PULSED LIGHT (IPL) therapy is indicated for use in surgical, aesthetic, and cosmetic applications. IPLs use flashlamps, computercontrolled power supplies, and bandpass...

Statin Drugs - Drug Safety Communication: Class Labeling Change

February 28, 2012 8:30 am | by U.S. Food & Drug Administration | News | Comments

New adverse event and liver enzyme monitoring information in statin labels and updated drug interactions information in lovastatin label.

Radiological Devices Panel of the Medical Devices Advisory Committee Meeting Announcement (April 11-12, 2012)

February 28, 2012 3:31 am | by U.S. Food & Drug Administration | News | Comments

This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public.

Advertisement

Norgestimate and Ethinyl Estradiol Tablets: Recall - Packaging Error, Potential for Incorrect Dosing Regimen

February 27, 2012 3:30 am | by U.S. Food & Drug Administration | News | Comments

Women may be left without adequate contraception, and at risk for unintended pregnancy.

Industry to CMS: Accuracy, Clarity of Sunshine Act Provisions Needed

February 24, 2012 1:30 pm | by U.S. Food & Drug Administration | News | Comments

Proposed Sunshine Act provisions for documenting devicemaker payments to physicians need more context and clarity, industry members say.

J & #38;J Taps Devices Unit Head to Replace Beleaguered CEO

February 24, 2012 1:30 pm | by U.S. Food & Drug Administration | News | Comments

Johnson & Johnson’s (J&J) upcoming CEO switch, from Bill Weldon to devices business head Alex Gorsky, could signal the company’s confidence in its ongoing relaunch of McNeil Consumer Products, an analyst says.

Nemschoff Chairs Perinatal Pediatric Hospital Bed (Bassinet): Class 1 Recall - Risk of Injury to Patients

February 24, 2012 7:30 am | by U.S. Food & Drug Administration | News | Comments

Doors and drawers may inadvertently open while bassinet is in motion; product may be difficult to maneuver due to it swivel caster configuration.

CareFusion Cortical Stimulator Control Unit: Class 1 Recall - Software Malfunction and Short Circuit

February 23, 2012 7:30 am | by U.S. Food & Drug Administration | News | Comments

Affects device and software that aids in the identification and mapping of areas of the brain.

Infants' TYLENOL Oral Suspension, 1 oz. Grape: Recall - Dosing System Complaints(2)

February 17, 2012 11:32 am | by U.S. Food & Drug Administration | News | Comments

Reports of dosing syringe flow restrictor being pushed into the bottle when inserting the syringe.

CDRH Transparency: 515 Program Initiative Status Update

February 17, 2012 5:31 am | by U.S. Food & Drug Administration | News | Comments

Updates to sorbent hemoperfusion system, cardiovascular permanent pacemaker electrode, CES, external pacemaker pulse generator, implantable pacemaker pulse generator, pacemaker programmers

Spinbrush Powered Toothbrush by Arm and Hammer or Crest: Safety Communication - Choking Hazard and Serious Injuries

February 16, 2012 10:31 am | by U.S. Food & Drug Administration | News | Comments

Brush head may break off in the user's mouth or near the face, causing cuts to the mouth and gums, chipped or broken teeth, swallowing and choking on the broken pieces, and injuries to the face and eyes.

Public Workshop - Design and Methodology for Postmarket Surveillance Studies under Section 522 of the Federal Food, Drug and Cosmetic Act, March 7, 2012

February 16, 2012 5:32 am | by U.S. Food & Drug Administration | News | Comments

This workshop is open to all interested parties, including professionals in the scientific community interested in advancing the infrastructure and methodology for postmarket surveillance studies. The purpose of the workshop is to provide a forum for...

FDA Safety Communication: Choking Hazard and Serious Injuries with the Spinbrush line of Powered Toothbrushes

February 16, 2012 5:31 am | by U.S. Food & Drug Administration | News | Comments

The FDA is aware of reports of serious injuries and potential hazards associated with the use of the Spinbrush. These reports indicated that while turned on, the brush head has either ?popped off? or broken off in the user?s mouth or near the face...

Avastin (bevacizumab): Counterfeit Product - FDA Issues Letters to 19 Medical Practices

February 14, 2012 5:32 pm | by U.S. Food & Drug Administration | News | Comments

The counterfeit version of Avastin does not contain the medicine's active ingredient, bevacizumab, which may have resulted in patients not receiving needed therapy.

Salter Labs 7600 Bubble Humidifier Used with Supplemental Oxygen Therapy: Class I Recall - Humidifier Lids Fail to Pop Off at the Intended Pressure

February 14, 2012 4:31 am | by U.S. Food & Drug Administration | News | Comments

The humidifier can leak and can potentially interrupt the flow of supplemental oxygen to the patient.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading